Arkema SA (OTCMKTS:ARKAY) Sees Large Decrease in Short Interest

Arkema SA (OTCMKTS:ARKAYGet Free Report) was the target of a large decrease in short interest in June. As of June 30th, there was short interest totaling 262 shares, a decrease of 77.9% from the June 15th total of 1,186 shares. Based on an average daily trading volume, of 2,036 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

ARKAY has been the topic of a number of recent analyst reports. The Goldman Sachs Group cut Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Arkema in a research report on Tuesday, June 23rd. Berenberg Bank downgraded Arkema from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Sanford C. Bernstein raised Arkema from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, Kepler Capital Markets downgraded Arkema from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce”.

View Our Latest Analysis on ARKAY

Arkema Trading Up 0.8%

Shares of ARKAY stock opened at $62.19 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.64 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $4.73 billion, a price-to-earnings ratio of 248.78 and a beta of 0.86. Arkema has a 12-month low of $56.28 and a 12-month high of $79.36. The stock’s 50-day moving average price is $68.31 and its 200-day moving average price is $66.80.

Arkema (OTCMKTS:ARKAYGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.10. The company had revenue of $2.57 billion during the quarter, compared to analyst estimates of $2.52 billion. Arkema had a return on equity of 4.06% and a net margin of 0.46%. Equities research analysts predict that Arkema will post 3.48 EPS for the current fiscal year.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

See Also

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.